|
⚲
|
| Keyboard |
| Diaz Luis
✚
|
|
|---|---|
| CIK # | 0001720081 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001720081] | |
| 4 | [0001720081] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Quest Diagnostics Inc | |
| Diaz Luis | |
| Jounce Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Quest Diagnostics Inc DGX
Common Stock
|
2025-05-15 | Grant | 1,203 | $0.00 | |
|
Quest Diagnostics Inc DGX
Common Stock
|
2024-05-16 | Grant | 1,482 | $0.00 | |
|
Quest Diagnostics Inc DGX
Common Stock
|
2023-05-17 | Grant | 1,369 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2023-05-03 | Disposed to issuer | 10,163 | ||
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2023-05-03 | Disposed to issuer | 15,700 | ||
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2023-05-03 | Disposed to issuer | 15,700 | ||
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2023-05-03 | Disposed to issuer | 15,700 | ||
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2023-05-03 | Disposed to issuer | 20,000 | ||
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2023-05-03 | Disposed to issuer | 27,100 | ||
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2022-06-24 | Grant | 20,000 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2021-06-18 | Grant | 15,700 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2020-06-26 | Grant | 13,550 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2019-06-12 | Grant | 15,700 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2018-06-19 | Grant | 10,163 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2017-10-20 | Grant | 27,100 | $0.00 |